O-(2-[18F]fluoroethyl)-L-tyrosine PET combined with MRI improves the diagnostic assessment of cerebral gliomas

Brain

Volumn 128, Issue 3, 2005, Pages 678-687

  Pauleit, Dirk ^a,c   Floeth, Frank ^c   Hamacher, Kurt ^a,b   Riemenschneider, Markus J ^c   Reifenberger, Guido ^c   Müller, Hans Wilhelm ^c   Zilles, Karl ^a,b   Coenen, Heinz H ^a,b   Langen, Karl Josef ^a,b  

^a FORSCHUNGSZENTRUM JÜLICH   (Germany)

^b Brain Imaging Center West   (Germany)

^c HEINRICH HEINE UNIVERSITY   (Germany)

Author keywords

Amino acid; FET; Glioma; MRI; PET

Indexed keywords

FLUORINE 18; O (2 FLUOROETHYL)TYROSINE F 18; TITANIUM; UNCLASSIFIED DRUG; DIAGNOSTIC AGENT; DRUG DERIVATIVE; FLUORINE; O (2 FLUOROETHYL)TYROSINE; O-(2-FLUOROETHYL)TYROSINE; TYROSINE;

ADOLESCENT; ADULT; AGED; ARTICLE; BRAIN BIOPSY; CHILD; CLINICAL ARTICLE; DIAGNOSTIC ACCURACY; FEMALE; GLIOMA; HISTOPATHOLOGY; HUMAN; LOGISTIC REGRESSION ANALYSIS; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PROSPECTIVE STUDY; RECEIVER OPERATING CHARACTERISTIC; SENSITIVITY AND SPECIFICITY; BIOPSY; BRAIN TUMOR; EVALUATION; METHODOLOGY; MIDDLE AGED; PATHOLOGY; PRESCHOOL CHILD; SCINTISCANNING;

ADOLESCENT; ADULT; AGED; BIOPSY; BRAIN NEOPLASMS; CHILD; CHILD, PRESCHOOL; FEMALE; FLUORINE RADIOISOTOPES; GLIOMA; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; POSITRON-EMISSION TOMOGRAPHY; PROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY; TYROSINE;

EID: 15044344615     PISSN: 00068950     EISSN: None     Source Type: Journal    
DOI: 10.1093/brain/awh399     Document Type: Article

References (41)

1. Bergstrom M, Collins VP, Ehrin E, Ericson K, Eriksson L, Greitz T, et al. Discrepancies in brain tumor extent as shown by computed tomography and positron emission tomography using [68Ga]EDTA, [11C]glucose, and [11C]methionine. J Comput Assist Tomogr 1983; 7: 1062-6.
2. Burger PC, Heinz ER, Shibata T, Kleihues P. Topographic anatomy and CT correlations in the untreated glioblastoma multiforme. Neurosurgery 1988; 68: 698-704.
3. Castillo M, Smith JK, Kwock L, Wilber K. Apparent diffusion coefficients in the evaluation of high-grade cerebral gliomas. AJNR Am J Neuroradiol 2001; 22: 60-4.
4. Chandrasoma PT, Smith MM, Apuzzo ML. Stereotactic biopsy in the diagnosis of brain masses: comparison of results of biopsy and resected surgical specimen. Neurosurgery 1989; 24: 160-5.
5. DeAngelis LM. Brain tumors. N Engl J Med 2001; 344: 114-23.
6. Goldman S, Levivier M, Pirotte B, Brucher JM, Wikler D, Damhaut P, et al. Regional glucose metabolism and histopathology of gliomas. A study based on positron emission tomography-guided Stereotactic biopsy. Cancer 1996; 78: 1098-106.
7. Hamacher K, Coenen HH. Efficient routine production of the 18F-labelled amino acid O-2-18F fluoroethyl-L-tyrosine. Appl Radiat Isot 2002; 57: 853-6.
8. Heiss P, Mayer S, Herz M, Wester HJ, Schwaiger M, Senekowitsch-Schmidtke R. Investigation of transport mechanism and uptake kinetics of O-(2-[18F]fluoroethyl)-L-tyrosine in vitro and in vivo. J Nucl Med 1999; 40: 1367-73.
9. Herholz K, Holzer T, Bauer B, Schroder R, Voges J, Ernestus RI, et al. 11C-methionine PET for differential diagnosis of low-grade gliomas. Neurology 1998; 50: 1316-22.
10. Jansen EP, Dewit LG, van Herk M, Bartelink H. Target volumes in radiotherapy for high-grade malignant gliomas of the brain. Radiother Oncol 2000; 56: 151-6.
11. Jacobs AH, Dittmar C, Winkeler A, Garlip G, Heiss WD. Molecular imaging of gliomas. Mol Imaging 2002; 1: 309-35.
12. Janus TJ, Kim EE, Tilbury R, Bruner JM, Yung WK. Use of [18F]fluorodeoxyglucose positron emission tomography in patients with primary malignant brain tumors. Ann Neurol 1993; 33: 540-8.
13. Johnson PC, Hunt SJ, Drayer BP. Human cerebral gliomas: correlation of postmortem MR imaging and neuropathologic findings. Radiology 1989; 170: 211-7.
14. Kaim AH, Weber B, Kurrer MO, Westera G, Schweitzer A, Gottschalk J, et al. (IS)F-FDG and (IS)F-FET uptake in experimental soft tissue infection. Eur J Nucl Med Mol Imaging 2002; 29: 648-54.
15. Kaschten B, Stevenaert A, Sadzot B, Deprez M, Degueldre C, Del Fiore G, et al. Preoperative evaluation of 54 gliomas by PET with fluorine-18- fluorodeoxyglucose and/or carbon-11-methionine. J Nucl Med 1998; 39: 778-85.
16. Kelly PJ, Daumas-Duport C, Kispert DB, Kail BA, Scheithauer BW, Illig JJ. Imaging-based stereotaxic serial biopsies in untreated intracranial glial neoplasms. J Neurosurg 1987; 66: 865-74.
17. Kleihues P, Louis DN, Scheithauer BW, Rorke LB, Reifenberger G, Burger PC, et al. The WHO classification of tumors of the nervous system. J Neuropathol Exp Neurol 2002; 61: 215-25.
18. Langen KJ, Jarosch M, Muhlensiepen H, Hamacher K, Broer S, Jansen P, et al. Comparison of fluorotyrosines and methionine uptake in F98 rat gliomas. Nucl Med Biol 2003; 30: 501-8.
19. Levivier M, Goldman S, Pirotte B, Brucher JM, Baleriaux D, Luxen A, et al. Diagnostic yield of Stereotactic brain biopsy guided by positron emission tomography with [18F]fluorodeoxyglucose. J Neurosurg 1995; 82: 445-52.
20. Lu S, Ahn D, Johnson G, Law M, Zagzag D, Grossman RI. Diffusion-tensor MR imaging of intracranial neoplasia and associated peritumoral edema: introduction of the tumor infiltration index. Radiology 2004; 232: 221-8.
21. Massager N, David P, Goldman S, Pirotte B, Wikler D, Salmon I, et al. Combined magnetic resonance imaging and positron emission tomography-guided Stereotactic biopsy in brainstem mass lesions: diagnostic yield in a series of 30 patients. J Neurosurg 2000; 93: 951-7.
22. McGirt MJ, Villavicencio AT, Bulsara KR, Friedman AH. MRI-guided Stereotactic biopsy in the diagnosis of glioma: comparison of biopsy and surgical resection specimen. Surg Neurol 2003; 59: 277-81.
23. Messing-Junger AM, Floeth FW, Pauleit D, Reifenberger G, Willing R, Gartner J, et al. Multimodal target point assessment for stereotactic biopsy in children with diffuse bithalamic astrocytomas. Childs Nerv Syst 2002; 18: 445-9.
24. Mosskin M, von Holst H, Bergstrom M, Collins VP, Eriksson L, Johnstrom P, et al. Positron emission tomography with 11C-methionine and computed tomography of intracranial tumours compared with histopathologic examination of multiple biopsies. Acta Radiol 1987; 28: 673-81.
25. Mosskin M, Ericson K, Hindmarsh T, von Holst H, Collins VP, Bergstrom M, et al. Positron emission tomography compared with magnetic resonance imaging and computed tomography in supratentorial gliomas using multiple stereotactic biopsies as reference. Acta Radiol 1989; 30: 225-32.
26. Ogawa T, Shishido F, Kanno I, Inugami A, Fujita H, Murakami M, et al. Cerebral glioma: evaluation with methionine PET. Radiology 1993; 186: 45-53.
27. Oppitz U, Maessen D, Zunterer H, Richter S, Flentje M. 3D-recurrence-patterns of glioblastomas after CT-planned postoperative irradiation. Radiother Oncol 1999; 53: 53-7.
28. Pauleit D, Floeth F, Herzog H, Hamacher K, Tellmann L, Muller HW, et al. Whole-body distribution and dosimetry of O-(2-[18F]fluoroethyl)-L-tyrosine. Eur J Nucl Med Mol Imaging 2003; 30: 519-24.
29. Pauleit D, Langen KJ, Floeth F, Hautzel H, Riemenschneider MJ, Reifenberger G, et al. Can the apparent diffusion coefficient be used as a noninvasive parameter to distinguish tumor tissue from peritumoral tissue in cerebral gliomas. J Magn Reson Imaging 2004; 20: 758-64.
30. Pirotte B, Goldman S, Salzberg S, Wikler D, David P, Vandesteene A, et al. Combined positron emission tomography and magnetic resonance imaging for the planning of stereotactic brain biopsies in children: experience in 9 cases. Pediatr Neurosurg 2003; 38: 146-55.
31. Pirotte B, Goldman S, Massager N, David P, Wikler D, Vandesteene A, et al. Comparison of 18F-FDG and 11C-methionine for PET-guided stereotactic brain biopsy of gliomas. J Nucl Med 2004; 45: 1293-8.
32. Pirzkall A, Nelson SJ, McKnight TR, Takahashi MM, Li X, Graves EE, Verhey LJ, et al. Metabolic imaging of low-grade gliomas with three-dimensional magnetic resonance spectroscopy. Int J Radiat Oncol Biol Phys 2002; 53: 1254-64.
33. Provenzale JM, McGraw P, Mhatre P, Guo AC, Delong D. Peritumoral brain regions in gliomas and meningiomas: investigation with isotropic diffusion-weighted MR imaging and diffusion-tensor MR imaging. Radiology 2004; 232: 451-60.
34. Rau FC, Weber WA, Wester HJ, Herz M, Becker I, Kruger A, et al. O-(2-[(18)F]Fluoroethyl)-L-tyrosine (FET): a tracer for differentiation of tumour from inflammation in murine lymph nodes. Eur J Nucl Med Mol Imaging 2002; 29: 1039-46.
35. Stadnik TW, Chaskis C, Michotte A, Shabana WM, van Rompaey K, Luypaert R, et al. Diffusion-weighted MR imaging of intracerebral masses: comparison with conventional MR imaging and histologic findings. AJNR Am J Neuroradiol 2001; 22: 969-76.
36. Vigneron D, Bollen A, McDermott M, Wald L, Day M, Moyher-Noworolski S, et al. Three-dimensional magnetic resonance spectroscopic imaging of histologically confirmed brain tumors. Magn Reson Imaging 2001; 19: 89-101.
37. Wallner KE, Galicich JH, Krol G, Arbit E, Malkin MG. Patterns of failure following treatment for glioblastoma multiforme and anaplastic astrocytoma. Int J Radiat Oncol Biol Phys 1989; 16: 1405-9.
38. Watanabe M, Tanaka R, Takeda N. Magnetic resonance imaging and histopathology of cerebral gliomas. Neuroradiology 1992; 34: 463-9.
39. Weber WA, Wester HJ, Grosu AL, Herz M, Dzewas B, Feldmann HJ, et al. O-(2-[18F]fluoroethyl)-L-tyrosine and L-[methyl-11C]methionine uptake in brain tumours: initial results of a comparative study. Eur J Nucl Med 2000; 27: 542-9.
40. Wester HJ, Herz M, Weber W, Heiss P, Senekowitsch-Schmidtke R, Schwaiger M, et al. Synthesis and radiopharmacology of O-(2-[18F] fluoroethyl)-L-tyrosine for tumor imaging. J Nucl Med 1999; 40: 205-12.
41. Wong TZ, van der Westhuizen GJ, Coleman RE. Positron emission tomography imaging of brain tumors. Neuroimaging Clin North Am 2002; 12: 615-26.